From: Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis
Patients with hepatoprotective drugs (N = 10)
Patients without hepatoprotective drug (N = 33)
P value
Sex
0.80
Male
7
24
Female
3
9
Age (years)
57 ± 21
55 ± 23
Peak AST (IU/dl)
66 ± 19
58 ± 12
0.20
Peak ALT (IU/dl)
72 ± 21
54 ± 21
0.058